908 Devices Inc. (MASS)
| Bid | 4.71 |
| Market Cap | 167.78M |
| Revenue (ttm) | 59.63M |
| Net Income (ttm) | -72.21M |
| EPS (ttm) | -2.12 |
| PE Ratio (ttm) | -2.24 |
| Forward PE | -7.69 |
| Analyst | Buy |
| Ask | 4.83 |
| Volume | 859,381 |
| Avg. Volume (20D) | 2,947,565 |
| Open | 4.55 |
| Previous Close | 4.53 |
| Day's Range | 4.49 - 4.95 |
| 52-Week Range | 1.81 - 7.48 |
| Beta | 0.30 |
About MASS
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials o...
Analyst Forecast
According to 3 analyst ratings, the average rating for MASS stock is "Buy." The 12-month stock price forecast is $6, which is an increase of 26.34% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · businesswire.com
Repligen Purchases Bioprocessing Analytics Portfolio from 908 DevicesWALTHAM, Mass., & BOSTON--(BUSINESS WIRE)--Repligen Corporation (Nasdaq: RGEN), a life sciences company focused on bioprocessing technology leadership, and 908 Devices Inc. (Nasdaq: MASS), a pioneer i...